CYTK
Cytokinetics, Incorporated
NASDAQ · Healthcare · Biotechnology · US
$72.72
−1.66%Leverage
- Debt / equity
- -7.32x
- Net debt / equity
- -5.85x
- Debt / assets
- 0.66x
- Debt / EBITDA
- -1.55x
- Net debt / EBITDA
- -1.24x
Liquidity & coverage
- Current ratio
- 6.66x
- Quick ratio
- 6.66x
- Cash ratio
- 6.43x
- Interest coverage
- -5.64x
- EBITDA / interest
- -6.56x
- Working capital
- $1.0B
Cash & dividend
- FCF / debt
- -0.46x
- Cash flow / debt
- -0.44x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026